Addex Therapeutics (ADXN) Assets (2018 - 2026)
Addex Therapeutics (ADXN) posted Assets of $6.1 million for Q1 2026, down 23.68% sequentially from $8.0 million in Q4 2025, and down 42.39% YoY from $10.5 million in Q1 2025.
Addex Therapeutics (ADXN) Assets (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Assets for 9 years, with the latest figure at $6.1 million in Q1 2026.
- Quarterly Assets fell 42.39% year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 million (down 42.39% YoY) and the FY2025 annual result came in at $7.7 million, down 36.76% from the prior year.
- Assets fell to $6.1 million in Q1 2026 per ADXN's latest filing, from $8.0 million in the prior quarter.
- Over five years, Assets peaked at $19.1 million in Q1 2022 and troughed at $3.8 million in Q1 2024.
- A 5-year average of $10.1 million and a median of $10.0 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets sank 64.83% in 2022, then surged 176.01% in 2025.
- Over 5 years, Assets stood at $8.6 million in 2022, then sank by 39.13% to $5.2 million in 2023, then soared by 132.93% to $12.2 million in 2024, then slumped by 34.68% to $8.0 million in 2025, then declined by 23.68% to $6.1 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $6.1 million, $8.0 million, and $9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | 6.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.08 Mn |
| Dec 31, 2025 | 7.96 Mn |
| Sep 30, 2025 | 9.16 Mn |
| Jun 30, 2025 | 10.27 Mn |
| Mar 31, 2025 | 10.55 Mn |
| Dec 31, 2024 | 12.19 Mn |
| Sep 30, 2024 | 14.04 Mn |
| Jun 30, 2024 | 15.15 Mn |
| Mar 31, 2024 | 3.82 Mn |
| Dec 31, 2023 | 5.23 Mn |
| Sep 30, 2023 | 6.95 Mn |
| Jun 30, 2023 | 10.01 Mn |
| Mar 31, 2023 | 7.89 Mn |
| Dec 31, 2022 | 8.60 Mn |
| Sep 30, 2022 | 12.68 Mn |
| Jun 30, 2022 | 11.82 Mn |
| Mar 31, 2022 | 19.15 Mn |
| Dec 31, 2021 | 24.45 Mn |
| Sep 30, 2021 | 19.67 Mn |
| Jun 30, 2021 | 23.61 Mn |